[1] Lopes JP, Agostinho P. CDK5: multitasking between physiological and pathological conditions[J]. Progress in Neurobiology, 2011, 94(1):49-63.
[2] Huang L, Dai T, Lin X, et al.MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells[J]. Biochemical & Biophysical Research Communications,2012, 425(2):127-133.
[3] Bevilacqua E, Frankenberger CA, Rosner MR. RKIP Suppresses Breast Cancer Metastasis to the Bone by Regulating Stroma-Associated Genes[J]. Int J Breast Cancer, 2012,(12):124704.
[4] Calabresi P, Picconi B, Parnetti L, et al. A convergent model for cognitive
dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine
synaptic balance[J]. Lancet Neurology, 2006, 5(11):974-983.
[5] Schapira AH. Mitochondria in the aetiology and pathogenesis of Parkinson's
disease[J]. Lancet Neurology, 2008, 7(1):97-109.
[6] Qu D, Rashidian J, Mount MP, et al. Role of CDK5-mediated
phosphorylation of prx2 in MPTP toxicity and parkinson's disease[J].
Neuron, 2007, 55(1):37-52.
[7] Coune PG, Schneider BL, Aebischer P. Parkinson's disease:gene therapies
[J]. Cold Spring Harb Perspect Med, 2012, 2(4):a009431.
|